Protectival & Tonix-R are well researched botanical formula in cancer care and widely used by integrative healthcare providers around the world.
In this upcoming webinar Dr. Yair Maimon, who led the development and research will present case studies which cover the main conditions Protectival & Tonix-R are used in the clinic as well as the supporting scientific evidences from our 15 years of research.
Through this webinar you will understand how to use the formulas in clinical practice and how Protectival & Tonix-R provide you an evidence based powerful and safe tools to support oncology and immune conditions.
The Webinar will include:
· Case studies on supporting patients at different stages of cancer.
· Insights on how to support variety of symptoms.
· Scientific evidence on the efficacy and safety.
· Dosage protocols and clinical applications.
· Live Q&A Session.
Join us on November 20th 11am EST (US) | 10am CST (US) | 8am PST (US) | 17:00 CET (Europe)
More from our Blog
In a new cell model study, the patented LCS101 formula eliminated up to 90% of cancer cells within 72 hours.
Nausea and vomiting are side effects of cancer therapy and affect most patients who have chemotherapy. Radiation therapy in certain cancer types can also create nausea
Breast Cancer Awareness Month is an opportunity to increase attention and support to early detection and treatment of breast cancer.